Company intelligence / Profile preview

Neol

Granada, Andalusia, Spain

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Neol Bioscience is a Spanish biotechnology company focused on the development of high-value products through industrial microbiology and microbial biotechnology. Originally a spin-off of Neuron Bio, the company specializes in the discovery and optimization of microorganisms for applications in health, nutrition, and energy. Its health division, Neol Health, focuses on the production of bioactive compounds such as Omega-3 fatty acids (DHA) and the development of microbial platforms for therapeutic discovery. The company utilizes a proprietary collection of over 15,000 microbial strains to identify novel solutions for neurodegenerative and metabolic diseases.

Therapeutic areas: NeurologyMetabolic Disorders
Modalities: Microbial therapySmall moleculeBiologic
Industry: Biotech

Partnerships

RepsolNeuron Bio

Beyond the preview

Go deeper on Neol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neol.

Explore the full profile